- Home
- KINS vs RPID Comparison
KINS vs RPID Comparison
Compare KINS & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KINS | RPID |
|---|---|---|
| Founded | 1886 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.7M | 204.3M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KINS | RPID |
|---|---|---|
| Price | $14.50 | $2.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 90.2K | ★ 263.3K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | ★ 94.59 | 2.78 |
| EPS | ★ 2.88 | N/A |
| Revenue | ★ $214,867,301.00 | $33,587,000.00 |
| Revenue This Year | $10.53 | $19.12 |
| Revenue Next Year | $15.00 | $18.42 |
| P/E Ratio | $5.05 | ★ N/A |
| Revenue Growth | ★ 38.50 | 19.74 |
| 52 Week Low | $13.08 | $1.86 |
| 52 Week High | $22.20 | $4.94 |
Technical Indicators
Market Signals| Indicator | KINS | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 40.16 | 32.95 |
| Support Level | $14.39 | N/A |
| Resistance Level | $15.58 | $4.48 |
| Average True Range (ATR) | 0.50 | 0.20 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 26.21 | 26.00 |
Price Performance
Historical ComparisonAbout KINS Kingstone Companies Inc.
Kingstone Companies Inc offers property and casualty insurance products through its subsidiary engaged in writing business through retail and wholesale agents and brokers. Its products include Personal lines, Livery physical damage, and Others. It operates in single segment, property and casualty insurance. It derives substantially all of its revenue from KICO, including revenues from earned premiums, ceding commissions from quota share reinsurance, net investment income generated from its investment portfolio, and net realized gains and losses on investment securities.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.